Humira
Adalimumab · KIT · AbbVie Inc.
Humira (adalimumab) is a injectable medication that works by suppressing the immune system to reduce inflammation and is used to treat conditions such as rheumatoid arthritis, psoriasis, Crohn's disease, and other autoimmune diseases. The medication comes as a kit with pre-filled pens or syringes for self-injection at home as directed by your doctor.
Key Facts
- Brand Name
- Humira
- Generic Name
- Adalimumab
- NDC Code (Product)
0074-2540- Manufacturer
- AbbVie Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125057
- Marketing Start
- 10/17/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is Humira used for?
Humira (adalimumab) is a injectable medication that works by suppressing the immune system to reduce inflammation and is used to treat conditions such as rheumatoid arthritis, psoriasis, Crohn's disease, and other autoimmune diseases. The medication comes as a kit with pre-filled pens or syringes for self-injection at home as directed by your doctor.
Is Humira a controlled substance?
Humira is not classified as a controlled substance by the DEA.
What is the generic name for Humira?
The generic name for Humira is Adalimumab. There are 9 other brand versions of Adalimumab.
What is the NDC code for Humira ?
The NDC (National Drug Code) for Humira is 0074-2540, listed by AbbVie Inc..